Cord Blood Mesenchymal Stem Cells Suppress DC-T Cell Proliferation via Prostaglandin B2

被引:14
作者
van den Berk, Lieke C. J. [1 ]
Jansen, Bas J. H. [1 ]
Snowden, Stuart [2 ]
Siebers-Vermeulen, Kim G. C. [1 ]
Gilissen, Christian [3 ]
Koegler, Gesine [4 ]
Figdor, Carl G. [1 ]
Wheelock, Craig E. [2 ]
Torensma, Ruurd [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands
[2] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Stockholm, Sweden
[3] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands
[4] Univ Dusseldorf, Sch Med, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany
关键词
MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; HLA-G; CYTOKINE PRODUCTION; DIFFERENTIATION; ANTIGEN; GROWTH; GANGLIOSIDES; INHIBIT; INDUCE;
D O I
10.1089/scd.2013.0433
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Immune suppression is a very stable property of multipotent stromal cells also known as mesenchymal stem cells (MSCs). All cell lines tested showed robust immune suppression not affected by a long culture history. Several mechanisms were described to account for this capability. Since several of the described mechanisms were not causing the immune suppression, the expression pattern of cord-blood-derived MSCs by microarray experiments was determined. Dendritic cells cocultured with cord blood MSCs were compared with cord blood MSCs. Putative immune suppressive candidates were tested to explain this inhibition. We find that cord blood MSCs themselves are hardly immunogenic as tested with allogeneic T-cells. Dendritic cells cocultured with second-party T-cells evoked abundant proliferation that was inhibited by third-party cord blood MSCs. Optimal inhibition was seen with one cord blood MSC for every dendritic cell. Blocking human leukocyte antigen G only saw partial recovery of proliferation. Several cytokines, gangliosides, enzymes like arginase, NO synthase, and indole amine 2,3-dioxygenase as well as the induction of Treg were not involved in the inhibition. The inhibiting moiety was identified as prostaglandin B2 by lipid metabolite analysis of the culture supernatant and confirmed with purified prostaglandin B2.
引用
收藏
页码:1582 / 1593
页数:12
相关论文
共 69 条
[1]   EFFECT OF PROSTAGLANDINS-A1, A2, B1, B2, E2 AND F2ALPHA ON HUMAN UMBILICAL-CORD VESSELS [J].
ADAIKAN, GP ;
KARIM, SMM .
PROSTAGLANDINS, 1974, 8 (05) :411-416
[2]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[3]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[4]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[5]   Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis [J].
Bennaceur, Karim ;
Popa, Iuliana ;
Portoukalian, Jacques ;
Berthier-Vergnes, Odile ;
Peguet-Navarro, Josette .
INTERNATIONAL IMMUNOLOGY, 2006, 18 (06) :879-886
[6]   THE ROLE OF GLYCOSPHINGOLIPIDS IN NATURAL IMMUNITY - GANGLIOSIDES MODULATE THE CYTOTOXICITY OF NATURAL-KILLER CELLS [J].
BERGELSON, LD ;
DYATLOVITSKAYA, EV ;
KLYUCHAREVA, TE ;
KRYUKOVA, EV ;
LEMENOVSKAYA, AF ;
MATVEEVA, VA ;
SINITSYNA, EV .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (11) :1979-1983
[7]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[8]   Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood [J].
Bieback, K ;
Kern, S ;
Klüter, H ;
Eichler, H .
STEM CELLS, 2004, 22 (04) :625-634
[9]  
Campioni D, 2008, CYTOM PART B-CLIN CY, V76, P225
[10]  
Cattan N, 2000, EUR CYTOKINE NETW, V11, P293